ArticleCancers2026

Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

Murat Günaltılı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.